Padmaja Kumari Rani, MD, L V Prasad Eye Institute, India
Wei Wang, MD, Sun Yat-sen University, China
BMC Ophthalmology called for submissions to our Collection, Diabetic ocular complications. We welcomed papers exploring diabetic ocular complications ranging from diabetic retinopathy, macular edema, cataracts, glaucoma, and neuro-ophthalmic manifestations.
This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being
Padmaja Kumari Rani, MD, L V Prasad Eye Institute, India
Dr Padmaja Kumari Rani is a vitreoretinal surgeon and an expert in the management of diabetic retinopathy with 23 years of professional experience. Dr Rani is currently a faculty of Anant Bajaj Retina Institute, Srimati Kanuri Shanthamma Centre for Vitreoretinal diseases, L V Prasad Eye Institute, Hyderabad (India) and Associate Director of Teleophthalmology. She has over 150 peer reviewed publications. She is the author of Sankara Nethralaya's Atlas of Retina Diseases.
Wei Wang, MD, Sun Yat-sen University, China
Dr Wei Wang is currently the ophthalmologist and assistant researcher at Zhongshan Ophthalmic Center, Sun Yat-sen University, and the member of Neuro Ophthalmology Professional Committee, China Association of Research Hospitals. He gained his Doctoral degree for Ophthalmology in Sun Yat-sen University, and worked as visiting fellow in Center for Eye Research Australia in Melbourne Australia from 2016 to 2017.
His research focuses on epidemic ophthalmology and imaging.
BMC Ophthalmology is calling for submissions to our Collection, Diabetic ocular complications.
Diabetes mellitus is a global health concern that affects millions of individuals worldwide. Its systemic manifestations are well-documented, but its effects on ocular health are equally significant. Diabetic ocular complications encompass a spectrum of conditions, ranging from diabetic retinopathy and macular edema to cataracts, glaucoma, and neuro-ophthalmic manifestations. These complications can result in severe vision impairment and even blindness, posing a significant public health challenge.
As diabetes continues to rise in prevalence worldwide, the burden of diabetic eye diseases is also increasing. Without a deeper comprehension of these complications, we risk compromising the visual well-being and overall quality of life for millions of individuals. Moreover, interdisciplinary research at the intersection of diabetes and ophthalmology has already yielded remarkable breakthroughs. Innovative diagnostic tools, such as optical coherence tomography (OCT) and anti-VEGF therapies, have transformed our ability to detect and manage diabetic retinopathy and macular edema. Looking ahead, the potential for further discoveries in genetics, regenerative medicine, and artificial intelligence-driven diagnostics holds promise for even more effective and personalized treatments. By continuing to advance our knowledge, we can aspire to a future where diabetic ocular complications no longer threaten the vision and livelihood of those affected by diabetes.
This Collection will showcase research exploring diabetic ocular complications, including but not limited to:
This collection supports and amplifies research related to SDG 3: Good Health & Well-Being
Image credit: TefiM / Getty Images / iStock
We aimed to evaluate microaneurysms (MAs) after treatment with anti-vascular endothelial growth factor (anti-VEGF) therapy to understand causes of chronic edema and anti-VEGF resistance.
Antidiabetic therapies are effective, but could indirectly modify the inflammatory response in the ocular microenvironment; therefore, a study was developed to evaluate the inflammatory cytokine profile in the...
To investigate the effectiveness of anti-vascular endothelial growth factor (VEGF) therapy on post-vitrectomy macular edema (PVME) and determine the risk factors for PVME recovery.
In this report, we describe a case of proliferative diabetic retinopathy that developed into exudative changes confusing with central serous chorioretinopathy (CSCR) following extensive endolaser pan retinal p...
This study aimed to explore differences in vitreous humour metabolites and metabolic pathways between patients with and without diabetic retinopathy (DR) and identify potential metabolite biomarkers.
The editorial outlines an integrated approach to managing diabetic ocular complications, combining advanced scientific research with practical public health strategies to improve the prevention, diagnosis, and...
Bilateral retinal detachment and choroidal detachment in a patient are rare occurrences. The presence of bilateral diabetic retinopathy (DR) in such a case is even rarer and complicates the condition.
To evaluate the short-term effects (hours-days) of intravitreal dexamethasone implant (IDI) in eyes with diabetic macular edema (DME) refractory to anti-vascular endothelial growth factor (VEGF) injections.
To find potential relation between retrobulbar vessels and fundus microvessels and to detect sensitive and effective clinical indicators in predicting the progress of diabetic retinopathy (DR), ocular hemodyna...
To study the changes of retinal function in type 2 diabetes mellitus(DM) patients without apparently diabetic retinopathy via multifocal electroretinogram. Methods: Thirty-six type 2 DM patients (72 eyes) with...
This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Diabetic ocular complications" from the dropdown menu.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.